ロード中...
Five criteria for using a surrogate endpoint to predict treatment effect based on data from multiple previous trials
A surrogate endpoint in a randomized clinical trial is an endpoint that occurs after randomization and before the true, clinically meaningful, endpoint that yields conclusions about the effect of treatment on true endpoint. A surrogate endpoint can accelerate the evaluation of new treatments but at...
保存先:
| 出版年: | Stat Med |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2017
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5771803/ https://ncbi.nlm.nih.gov/pubmed/29164641 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sim.7561 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|